Bio-Rad Laboratories (BIO) Net Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Net Margin of 89.02% for Q1 2026, down 9995.0% year-over-year from N/an in Q1 2025, and down 185.71% quarter-over-quarter from 103.87% in Q4 2025.
Bio-Rad Laboratories (BIO) Net Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Net Margin for 18 consecutive years, with 89.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin fell 9995.0% year-over-year to 89.02%; the TTM figure through Mar 2026 stood at 6.52% (up 9168.0% YoY), while the FY2025 annual figure was 29.42%, up 10127.0% from the prior year.
- Net Margin eased to 89.02% in Q1 2026 per BIO's latest filing, from 103.87% in the prior quarter.
- Across five years, Net Margin topped out at 113.35% in Q4 2022 and bottomed at 480.98% in Q1 2022.
- Historically, Net Margin has averaged 51.68% across 5 years, with a median of 10.19% in 2023.
- Annual changes were most pronounced in 2022 — Net Margin sank 61546 bps — and 2023, when it jumped 49117 bps.
- Bio-Rad Laboratories' Net Margin stood at 113.35% in 2022, then tumbled by 55 bps to 51.34% in 2023, then slumped by 309 bps to 107.24% in 2024, then surged by 197 bps to 103.87% in 2025, then sank by 186 bps to 89.02% in 2026.
- Business Quant data shows BIO's Net Margin at 89.02% in Q1 2026, 103.87% in Q4 2025, and 52.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.47% |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | 57.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.05% |
| Mar 31, 2026 | -89.02% |
| Dec 31, 2025 | 103.87% |
| Sep 30, 2025 | -52.36% |
| Jun 30, 2025 | 48.77% |
| Mar 31, 2025 | 10.93% |
| Dec 31, 2024 | -107.24% |
| Sep 30, 2024 | 100.54% |
| Jun 30, 2024 | -339.15% |
| Mar 31, 2024 | 62.85% |
| Dec 31, 2023 | 51.34% |
| Sep 30, 2023 | 16.81% |
| Jun 30, 2023 | -170.64% |
| Mar 31, 2023 | 10.19% |
| Dec 31, 2022 | 113.35% |
| Sep 30, 2022 | -23.91% |
| Jun 30, 2022 | -133.86% |
| Mar 31, 2022 | -480.98% |
| Dec 31, 2021 | -213.60% |
| Sep 30, 2021 | 525.84% |